These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Disseminated intravascular clotting in liver cirrhosis]. Krug H; Dziewolska M; Sidor H; Gluszek J Pol Arch Med Wewn; 1973 Mar; 50(3):243-9. PubMed ID: 4692441 [No Abstract] [Full Text] [Related]
7. Enhanced expression of monocyte tissue factor in patients with liver cirrhosis. Saliola M; Lorenzet R; Ferro D; Basili S; Caroselli C; Santo AD; Sallese M; Violi F Gut; 1998 Sep; 43(3):428-32. PubMed ID: 9863491 [TBL] [Abstract][Full Text] [Related]
8. Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis. The CALC Group. Coagulation Abnormalities in Liver Cirrhosis. Violi F; Ferro D; Basili S; Quintarelli C; Musca A; Cordova C; Balsano F Hepatology; 1993 Jan; 17(1):78-83. PubMed ID: 8423044 [TBL] [Abstract][Full Text] [Related]
9. Ongoing prothrombotic state in the portal circulation of cirrhotic patients. Violi F; Ferro D; Basili S; Lionetti R; Rossi E; Merli M; Riggio O; Bezzi M; Capocaccia L Thromb Haemost; 1997 Jan; 77(1):44-7. PubMed ID: 9031447 [TBL] [Abstract][Full Text] [Related]
10. Disseminated intravascular coagulation with increased fibrinolysis during the early phase of isolated traumatic brain injury. Wada T; Gando S; Maekaw K; Katabami K; Sageshima H; Hayakawa M; Sawamura A Crit Care; 2017 Aug; 21(1):219. PubMed ID: 28826407 [TBL] [Abstract][Full Text] [Related]
11. Disseminated intravascular coagulation in cirrhosis. Carr JM Hepatology; 1989 Jul; 10(1):103-10. PubMed ID: 2661390 [No Abstract] [Full Text] [Related]
12. [Determination of plasma level of platelet activating factor in cirrhotic patients and its relation to endotoxemia]. Zeng N Zhonghua Yi Xue Za Zhi; 1992 Mar; 72(3):141-3, 189. PubMed ID: 1319804 [TBL] [Abstract][Full Text] [Related]
14. Clotting activation and hyperfibrinolysis in cirrhosis: implication for bleeding and thrombosis. Violi F; Ferro D Semin Thromb Hemost; 2013 Jun; 39(4):426-33. PubMed ID: 23487343 [TBL] [Abstract][Full Text] [Related]
15. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction. Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093 [TBL] [Abstract][Full Text] [Related]
16. High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemia. Ferro D; Quintarelli C; Lattuada A; Leo R; Alessandroni M; Mannucci PM; Violi F Hepatology; 1996 Jun; 23(6):1377-83. PubMed ID: 8675154 [TBL] [Abstract][Full Text] [Related]
17. [Evaluation of several parameters of coagulation in liver cirrhosis: disseminated intravascular coagulation or pseudo-disseminated intravascular coagulation?]. Petrella V; Parachini F; Rigotti T; Galimberti M; Cusumano S Minerva Med; 1988 Mar; 79(3):193-8. PubMed ID: 3362400 [TBL] [Abstract][Full Text] [Related]
18. Concentration of prothrombin fragment 1 + 2 (f1 + 2) in patients with liver cirrhosis and chronic hepatitis C infection. Fota-Markowska H; Modrzewska R; Krzowska-Firych J; Lis-Tønder J; Borowicz I Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):4-7. PubMed ID: 16146040 [TBL] [Abstract][Full Text] [Related]
19. A case of liver cirrhosis complicated with endotoxemia and disseminated intravascular coagulation: a case report. Yajima Y; Otsuki M; Suzuki H; Mori K; Goto Y Tohoku J Exp Med; 1987 Mar; 151(3):269-74. PubMed ID: 3109073 [TBL] [Abstract][Full Text] [Related]
20. Ascites fluid as a possible origin for hyperfibrinolysis in advanced liver disease. Agarwal S; Joyner KA; Swaim MW Am J Gastroenterol; 2000 Nov; 95(11):3218-24. PubMed ID: 11095345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]